RESUMEN
The study of nutraceuticals and their connection to immunity is an expanding field of research. The use of nutraceuticals to alleviate stress and enhance immunity in adverse aquaculture environments have been examined to a certain extent. To elucidate the understanding, we focused on the immunological effect of membrane-separated 13% anthocyanin standardized elderberry (EB) extract with maltodextrin excipient, widely used first-line nutraceuticals to augment the immunity, in aquaculture fish, Nile tilapia. To evaluate the potential of EB-extract, we assessed their capability to enhance lymphocyte proliferation and interleukin-2 production in an in-vitro condition using spleen and thymus lymphocytes. The experiments on spleen and thymus T-cells demonstrated significantly higher T-cell proliferation by EB-extract when lectin mitogen Con A was present as a stimulator. Likewise, our spleen B-cell proliferation result reveals a significant effect of EB-extracts, along with B-cell stimulator non-lectin mitogen LPS. Further, the quantification of IL-2 indicates elevated IL-2 levels when spleen T-cells were cultured with EB-extracts and with Con A present as a stimulator. These suggest that 13% anthocyanin standardized EB-extracts can aggrandize fish cells' cellular and humoral immune responses. With further research, elderberry extracts could be used to supplement commercial feed in aquaculture to reduce stress and stimulate the immune response.
Asunto(s)
Cíclidos , Enfermedades de los Peces , Sambucus nigra , Sambucus , Animales , Antocianinas/farmacología , Mitógenos , Interleucina-2 , Suplementos Dietéticos , Extractos Vegetales/farmacología , Alimentación Animal/análisis , DietaRESUMEN
Cannabidiol (CBD) is one of the most popular emerging plant extracts that is being investigated for its wide range of potential health benefits. This experiment tests how B16 mice melanoma cells, are affected by four different concentrations (0.2 mg/mL, 0.04 mg/mL, 0.008 mg/mL and 0.0016 mg/mL) of 99% CBD oil. The results of this experiment demonstrate that CBD significantly inhibited melanoma cell growth in-vitro at 0.2 mg/mL and 0.04 mg/mL. This shows that CBD has the potential to inhibit melanoma cell growth in vertebrates, namely mice.
Asunto(s)
Antineoplásicos Fitogénicos/farmacología , Cannabidiol/farmacología , Melanoma/tratamiento farmacológico , Extractos Vegetales/farmacología , Animales , Antineoplásicos Fitogénicos/química , Cannabidiol/química , Cannabis/química , Línea Celular Tumoral , Proliferación Celular/efectos de los fármacos , Relación Dosis-Respuesta a Droga , Ensayos de Selección de Medicamentos Antitumorales , Melanoma/patología , Ratones , Extractos Vegetales/químicaRESUMEN
Study was conducted on mouse spleen cells, cultured and incubated in-vitro with Holy basil and Thai basil, to observe their effect on proliferation. Four dilutions, namely 1:1, 1:5, 1:25, and 1:125, for both Holy basil and Thai Basil were used separately, in presence and absence of mitogen, Concanavalin A (Con A) to stimulate the T cells. Cell proliferation was monitored by 3 H- thymidine radioisotope incorporation. Spleen cells (macrophages, B and T cells) showed significantly more proliferation at 1:1 dilution than control (cells with no factor), incubated with Holy basil (in assay without Con A). Spleen T cells, however, did not show any significance in proliferation at same dilution, 1:1, with Holy basil with Con A. All other dilutions (with or without Con A), for either Holy basil or Thai basil, did not show any significant changes in proliferation when compared to control.